Cargando…

Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer

Thyroid cancer is the most well-known type of endocrine cancer that is easily treatable and can be completely cured in most cases. Nonetheless, anti-cancer drug-resistant metastasis or recurrence may occur and lead to the failure of cancer therapy, which eventually leads to the death of a patient wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yuna, Yun, Hyeok Jun, Choi, Kyung Hwa, Kim, Chan Wung, Lee, Jae Ha, Weicker, Raymond, Kim, Seok-Mo, Park, Ki Cheong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671409/ https://www.ncbi.nlm.nih.gov/pubmed/38003602 http://dx.doi.org/10.3390/ijms242216413

Ejemplares similares

Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2022)

Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
por: Chang, Hang-Seok, et al.
Publicado: (2023)

Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma
por: Lim, Jin Hong, et al.
Publicado: (2022)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
por: Kim, Soo Young, et al.
Publicado: (2018)

Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer
por: Kim, Seok-Mo, et al.
Publicado: (2020)

Accelerated Disease Progression after Discontinuation of Sorafenib in a Patient with Metastatic Papillary Thyroid Cancer
por: Yun, Kyung-Jin, et al.
Publicado: (2014)

Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer
por: Yun, Hyeok Jun, et al.
Publicado: (2022)

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models
por: Yun, Hyeok Jun, et al.
Publicado: (2021)

Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer
por: Park, Ki Cheong, et al.
Publicado: (2017)

Discovery of Pharmaceutical Composition for Prevention and Treatment in Patient-Derived Metastatic Medullary Thyroid Carcinoma Model
por: Yun, Hyeok-Jun, et al.
Publicado: (2022)

Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
por: Kim, Soo Young, et al.
Publicado: (2019)

Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer
por: Yun, Hyeok Jun, et al.
Publicado: (2023)

Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm
por: Lee, Jin Seok, et al.
Publicado: (2022)

Solitary lateral neck node metastasis in papillary thyroid carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2014)

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

The Clinical Significance of the Right Para-Oesophageal Lymph Nodes in Papillary Thyroid Cancer
por: Chang, Hojin, et al.
Publicado: (2015)

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153]
por: Park, Ki Cheong, et al.
Publicado: (2017)

PPARγ Targets-Derived Diagnostic and Prognostic Index for Papillary Thyroid Cancer
por: Kim, Jaehyung, et al.
Publicado: (2021)

Papillary thyroid cancer in black thyroid: a case report and literature review
por: Kim, Min Jhi, et al.
Publicado: (2023)

Ultrasonographic features and clinicopathologic characteristics of macrofollicular variant papillary thyroid carcinoma
por: Lee, Yong Sang, et al.
Publicado: (2018)

Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer()()
por: Choi, Kyung Hwa, et al.
Publicado: (2018)

Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis
por: Lee, Jin-Seok, et al.
Publicado: (2022)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

Identification of Differentially Expressed Genes in Papillary Thyroid Cancers
por: Lee, Ki-Young, et al.
Publicado: (2009)

Pathologic Spectrum of Lymphocytic Infiltration and Recurrence of Papillary Thyroid Carcinoma
por: Kim, Hyun Gi, et al.
Publicado: (2014)

Overcoming the Limitations of Fine Needle Aspiration Biopsy: Detection of Lateral Neck Node Metastasis in Papillary Thyroid Carcinoma
por: Jun, Hak Hoon, et al.
Publicado: (2015)

Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study
por: Jeong, Chaiho, et al.
Publicado: (2020)

Clinicopathological and Genetic Characteristics of Patients of Different Ages with Diffuse Sclerosing Variant Papillary Thyroid Carcinoma
por: Kim, Soo-Young, et al.
Publicado: (2023)

A Case of Papillary Thyroid Cancer Recurring as an Esophageal Submucosal Tumor
por: Seoung, Hyeog Gyu, et al.
Publicado: (2012)

Microarray Analysis of Papillary Thyroid Cancers in Korean
por: Kim, Hyun Sook, et al.
Publicado: (2010)

Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound
por: Hwang, Sena, et al.
Publicado: (2015)

Hand-foot syndrome associated with use of sorafenib in a patient with papillary thyroid cancer: a case report
por: Velandia-Carrillo, Carlos, et al.
Publicado: (2014)

Papillary thyroid cancer with suspicious uterine cervix metastasis: a case report and literature review
por: Kim, Min Jhi, et al.
Publicado: (2022)

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014)

Papillary thyroid microcarcinoma in a thyroid pyramidal lobe
por: Ha, Tae Kwun, et al.
Publicado: (2014)

Relationship between ultrasonographic and pathologic calcification patterns in papillary thyroid cancer
por: Kim, Bu Kyung, et al.
Publicado: (2018)

Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays
por: Chung, Ki-Wook, et al.
Publicado: (2012)

Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib
por: Hussain, Syed Zubair, et al.
Publicado: (2013)

Extremely Well-Differentiated Papillary Thyroid Carcinoma Resembling Adenomatous Hyperplasia Can Metastasize to the Skull: A Case Report
por: Pyo, Ju Yeon, et al.
Publicado: (2017)

SAT573 Incidental Discovery Of CHEK2 Mutation With Papillary Thyroid Cancer
por: Thelmo, Franklin L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_93sqdm89kbs6l64vi20nm9nthv